Scientific background
Articles
Concepts and mitigation strategies
To ensure the long-term protection of ecosystems such as water bodies and soils, and for preventive health protection, the entry of pharmaceuticals into the environment must be sustainably reduced throughout the entire lifecycle of medicinal products.
Environmental aspects of the authorisation of human medicinal pro
The assessment of the environmental impact of human and veterinary medicinal products has been an integral part of the authorisation process for many years. In Germany, this has been a legal requirement since 1998. The UBA is responsible for conducting the environmental risk assessment.
Environmental effects of pharmaceutical substances
Despite the fact that, according to current knowledge, there are no known effects on human health, precautionary action should be taken to reduce the release of pharmaceutical substances into the environment, especially as there is still no knowledge of the effects of chronic intake – even at low concentrations – on humans and the environment.
Entry and occurrence of human pharmaceuticals in the environment
Residues of pharmaceuticals contaminate water bodies and soils worldwide. They have also been detected in groundwater and, in some cases, even in drinking water. Human pharmaceuticals enter wastewater primarily through human excretion and then pass through sewage treatment plants into water bodies. Due to increasing pharmaceutical consumption, environmental pollution is expected to rise.